Pharma Journalist -

The U.S. FDA approved Rydapt (midostaurin) in combination with Chemotherapy for the treatment of adult patients with newly diagnosed AML (acute myeloid leukemia) who have a specific…
Read More...

MedMira has received CE mark on its syphilis/HIV rapid test, Multiplo TP/HIV, this approval allows company to market and distribute the multiplex rapid test throughout the European…
Read More...

Allergan announced that it has completed the acquisition of ZELTIQ Aesthetics for $2.4 billion cash. ZELTIQ stockholders approved the transaction during the meeting held on April 27,…
Read More...

enGene announced that Theresa Podrebarac, has been appointed as the  Chief Medical Officer of the company. He will be responsible for designing and executing clinical development plan…
Read More...

The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to Pfizer’s lorlatinib for the treatment of patients with anaplastic lymphoma kinase…
Read More...

Takeda Pharmaceutical has entered into a multi-year partnership with Harrington Discovery Institute at University Hospitals in Cleveland, Ohio to advance the development of rare disease…
Read More...

A new sPCMA white paper – "PBM Specialty Pharmacies Improve Patient Outcomes and Reduce Costs" – describes how pharmacy benefit managers (PBMs) use specialty pharmacies to reduce…
Read More...

TESARO an oncology-focused biopharmaceutical company, announced that following the recent identification of a fixed dose and patient-centric dosing schedule, the ongoing clinical trial…
Read More...

Pharma Major Lupin Limited (Lupin) announced today that it has received final approval for its Olmesartan Medoxomil tablets, 5 mg, 20 mg and 40 mg from the United States Food and Drug…
Read More...

Amcor, a global leader in responsible packaging solutions, will showcase some of its latest packaging solutions for food and beverage, home and personal care, medical and pharmaceutical…
Read More...